These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8652366)

  • 41. Bisphosphonates may potentiate effects of thalidomide-dexamethasone combination in advanced multiple myeloma.
    Ural AU; Avcu F
    Am J Hematol; 2006 May; 81(5):385-6; author reply 386. PubMed ID: 16628715
    [No Abstract]   [Full Text] [Related]  

  • 42. Third North American Symposium on Skeletal Complications of Malignancy: summary of the scientific sessions.
    Mohla S; Weilbacher KN; Cher ML; Oyajobi BO; Poznak CV; Clohisy DR
    Cancer; 2003 Feb; 97(3 Suppl):719-25. PubMed ID: 12548568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bisphosphonates in the treatment of multiple myeloma].
    Stajszczyk M
    Przegl Lek; 2002; 59(1):37-42. PubMed ID: 12108045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Biphosphonates and multiple myeloma].
    Mazières B; Laroche M; Cantagrel A
    Bull Cancer; 1993; 80(10 Suppl):45-9. PubMed ID: 8081030
    [No Abstract]   [Full Text] [Related]  

  • 45. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.
    Bloomfield DJ
    J Clin Oncol; 1998 Mar; 16(3):1218-25. PubMed ID: 9508210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ibandronate in oncology.
    Burckhardt P
    Cancer; 1997 Oct; 80(8 Suppl):1696-8. PubMed ID: 9362439
    [No Abstract]   [Full Text] [Related]  

  • 47. Bisphosphonate treatment for multiple myeloma.
    Terpos E; Rahemtulla A
    Drugs Today (Barc); 2004 Jan; 40(1):29-40. PubMed ID: 14988768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
    Coleman RE
    Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bisphosphonates: expanded roles in the treatment of patients with cancer.
    Viale PH; Sanchez Yamamoto D
    Clin J Oncol Nurs; 2003; 7(4):393-401. PubMed ID: 12929272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
    Guay DR
    Pharmacotherapy; 2006 May; 26(5):655-73. PubMed ID: 16637795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pamidronate in the treatment of osteolytic bone metastases in breast cancer patients.
    Theriault R
    Br J Clin Pract Suppl; 1996 Sep; 87():8-12; discussion 13-4. PubMed ID: 8995011
    [No Abstract]   [Full Text] [Related]  

  • 52. Multiple myeloma.
    Altundag K; Altundag O; Gundeslioglu O
    N Engl J Med; 2005 Feb; 352(8):840-1; author reply 840-1. PubMed ID: 15728824
    [No Abstract]   [Full Text] [Related]  

  • 53. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bisphosphonates for bone metastasis of malignant tumor].
    Kaise H; Kohno N
    Clin Calcium; 2006 Apr; 16(4):655- 64. PubMed ID: 16582518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metastatic bone disease: role of bisphosphonates.
    McKenna MJ; Freaney R; Crown J
    Ir Med J; 1995; 88(6):189. PubMed ID: 8575911
    [No Abstract]   [Full Text] [Related]  

  • 56. [Bisphosphonates. A neu therapy principle in calcium and bone metabolism disorders].
    Raue F
    Internist (Berl); 1999 Apr; 40(4):448-55. PubMed ID: 10354947
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral bisphosphonates: A review of clinical use in patients with bone metastases.
    Major PP; Lipton A; Berenson J; Hortobagyi G
    Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in the biology and treatment of myeloma bone disease.
    Berenson JR
    Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S16-20. PubMed ID: 11757204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical trials of bisphosphonates in multiple myeloma.
    Mahindra A; Pozzi S; Raje N
    Clin Adv Hematol Oncol; 2012 Sep; 10(9):582-7. PubMed ID: 23073123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone disease in multiple myeloma: new markers, new treatments.
    Joshua D
    Intern Med J; 2001 Jul; 31(5):261-3. PubMed ID: 11512595
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.